Challenges in quantifying biosphere–atmosphere exchange of nitrogen species
Recent research in nitrogen exchange with the atmosphere has separated research communities
according to N form. The integrated perspective needed to quantify the net effect of N …
according to N form. The integrated perspective needed to quantify the net effect of N …
Ecological impacts of atmospheric pollution and interactions with climate change in terrestrial ecosystems of the Mediterranean Basin: Current research and future …
Mediterranean Basin ecosystems, their unique biodiversity, and the key services they provide
are currently at risk due to air pollution and climate change, yet only a limited number of …
are currently at risk due to air pollution and climate change, yet only a limited number of …
Child participation in the early years: Challenges for education
M Theobald, S Danby… - Australasian Journal of …, 2011 - journals.sagepub.com
THE VIEW THAT CHILDREN should have a say in and participate in the decision making of
matters that affect them is now an accepted position when considering research and policy …
matters that affect them is now an accepted position when considering research and policy …
Efficacy and safety of gemtuzumab ozogamicin in patients with CD33-positive acute myeloid leukemia in first relapse
EL Sievers, RA Larson, EA Stadtmauer… - Journal of Clinical …, 2001 - ascopubs.org
PURPOSE: Three open-label, multicenter trials were conducted to evaluate the efficacy and
safety of single-agent Mylotarg (gemtuzumab ozogamicin; CMA-676; Wyeth Laboratories, …
safety of single-agent Mylotarg (gemtuzumab ozogamicin; CMA-676; Wyeth Laboratories, …
Anton, a special-purpose machine for molecular dynamics simulation
The ability to perform long, accurate molecular dynamics (MD) simulations involving proteins
and other biological macro-molecules could in principle provide answers to some of the …
and other biological macro-molecules could in principle provide answers to some of the …
Anton 2: raising the bar for performance and programmability in a special-purpose molecular dynamics supercomputer
DE Shaw, JP Grossman, JA Bank… - SC'14: Proceedings …, 2014 - ieeexplore.ieee.org
Anton 2 is a second-generation special-purpose supercomputer for molecular dynamics
simulations that achieves significant gains in performance, programmability, and capacity …
simulations that achieves significant gains in performance, programmability, and capacity …
Cerebral MR venography: normal anatomy and potential diagnostic pitfalls
RH Ayanzen, CR Bird, PJ Keller… - American Journal …, 2000 - Am Soc Neuroradiology
BACKGROUND AND PURPOSE: MR venography is often used to examine the intracranial
venous system, particularly in the evaluation of dural sinus thrombosis. The purpose of this …
venous system, particularly in the evaluation of dural sinus thrombosis. The purpose of this …
Results of a HOVON/SAKK donor versus no-donor analysis of myeloablative HLA-identical sibling stem cell transplantation in first remission acute myeloid leukemia in …
JJ Cornelissen, WLJ Van Putten, LF Verdonck… - Blood, 2007 - ashpublications.org
The Dutch-Belgian Hemato-Oncology Cooperative Group and the Swiss Group for Clinical
Cancer Research (HOVON-SAKK) collaborative study group evaluated outcome of patients (…
Cancer Research (HOVON-SAKK) collaborative study group evaluated outcome of patients (…
Final report of the efficacy and safety of gemtuzumab ozogamicin (Mylotarg) in patients with CD33‐positive acute myeloid leukemia in first recurrence
RA Larson, EL Sievers, EA Stadtmauer, B Löwenberg… - Cancer, 2005 - Wiley Online Library
BACKGROUND In this study, the authors analyzed the efficacy and safety of gemtuzumab
ozogamicin (GO) (Mylotarg®), an antibody‐targeted chemotherapy for CD33‐positive acute …
ozogamicin (GO) (Mylotarg®), an antibody‐targeted chemotherapy for CD33‐positive acute …
[HTML][HTML] Cytarabine dose for acute myeloid leukemia
B Löwenberg, T Pabst, E Vellenga… - … England Journal of …, 2011 - Mass Medical Soc
Background Cytarabine (ara-C) is an important drug in the treatment of acute myeloid leukemia
(AML). High-dose cytarabine (2000 to 3000 mg per square meter of body-surface area) …
(AML). High-dose cytarabine (2000 to 3000 mg per square meter of body-surface area) …